DADimitrios Angelis

Dimitrios Angelis

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Dimitrios Angelis has a total of 69 co-authors. Here are the top co-authors by number of shared publications:

  • Jawahar Jagarapu

    Department of Pediatrics, Division of Neonatal-Perinatal Medicine, University of Texas Southwestern Medical Center

    5 shared publications
  • Lina Chalak

    Division of Neonatal-Perinatal Medicine, Department of Pediatrics, The University of Texas Southwestern Medical Center, Dallas, TX, USA

    5 shared publications
  • Luc Pierre Brion

    Division of Neonatal-Perinatal Medicine, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, USA

    4 shared publications
  • Maria Delivoria-Papadopoulos

    3 shared publications
  • Robert Bennett

    Texas Tech University Health Sciences Center Odessa Texas

    3 shared publications
  • Amanda Hughes

    Texas Tech University Health Sciences Center Odessa Texas

    2 shared publications

Latest Publications

  • Open Access

    Effects of a five-day neuroprotective care bundle on severe intraventricular hemorrhage and mortality in extremely low birth weight neonates: a retrospective evaluation across three practice eras

    by Nicole A. Bailey, Arya Batta, Jawahar Jagarapu, Gina Lafferty, Christina Chan, Katherine M. Holtzman, Michelle Hagans, Dimitrios Angelis

    Background: Neuroprotective bundles of care (BoC) aim to reduce intraventricular hemorrhage (IVH) in extremely preterm infants, but optimal duration and interaction with physiologic risk factors such as hypercapnia remain uncertain. Methods: We performed a single-center retrospective cohort study of infants born ≤28 weeks of gestation or with extremely low birth weight (2 ). CO 2 /outcome relationships were examined by era. Results: Among 285 infants, unadjusted outcomes were similar across eras; however, after adjustment for measured differences in illness severity and physiologic risk factors, the 5-day BoC era was associated with lower odds of death and the composite outcome. Higher maximum arterial CO 2 was associated with increased predicted risk of severe IVH and the composite outcome across eras. Conclusions: The 5-day BoC era was associated with improved adjusted outcomes despite similar unadjusted IVH rates. Because implementation coincided with other evolving neonatal practices, including higher use of noninvasive respiratory support these findings should be interpreted as an era-associated effect rather than an isolated effect of bundle duration. Prospective studies are needed to determine the independent contribution and optimal duration of neuroprotective bundles.

  • Risk factors for subgaleal hemorrhage and adverse early neonatal outcomes: a single-center cohort study with exclusive use of forceps

    by Pranav Viswanathan, Jawahar Jagarapu, Nicole A. Bailey, June Hu, Kikelomo Babata, L. Steven Brown, Patti J. Burchfield, Dimitrios Angelis

    Subgaleal hemorrhage (SGH) in neonates ranges from benign bleeds to life-threatening shock. Even small SGH may be linked with parenchymal brain injury and hypoxic-ischemic insult. This study aimed to characterize clinical and neuroimaging features of SGH and identify predictors of early abnormal outcomes or death. We retrospectively reviewed all SGH cases admitted to a high-volume Dallas NICU over 11 years, where forceps are exclusively used for operative vaginal deliveries. Data included demographics, clinical and laboratory findings, neuroimaging, and outcomes. Severe outcome was defined as abnormal neurologic exam at discharge, seizures, encephalopathy, or death. Among 141,448 live births, 43 neonates required further care in the NICU for SGH (approximate incidence: 3 per 10,000 live births). Of these, two infants died, and 23% experienced severe outcomes. Volume expansion and metabolic acidosis predicted severity. MRI identified additional lesions not evident on ultrasound. SGH requiring NICU care may signal broader neurologic injury. MRI aids diagnosis, while exclusive forceps use was associated with lower SGH incidence and mortality.

  • Ketogenic diet in neonates: effects, pitfalls, and a paradigm from a preterm newborn affected by pyruvate dehydrogenase deficiency

    by Sokratis Katsoudas, Luis A. Umana, Rebekah Clarke, Jennifer Thomas, Michelle Machie, Dimitrios Angelis

    The application of ketogenic diet (KD) in newborns is rare and mainly reserved for specific metabolic and seizure disorders. Furthermore, only case reports describe the effects of KD in premature infants. Here, we summarize the recent advances, indications, mechanisms of action and practical issues related to KD. We also provide a paradigm of a preterm male infant born at 34 weeks with pyruvate dehydrogenase deficiency, highlighting the therapeutic challenges and outcomes with the KD. This report underscores the complexities of managing metabolic disorders in neonates and the effects of KD.

  • Open Access

    Improved linear growth after routine zinc supplementation in preterm very low birth weight infants

    by Tina A. Seidu, Luc P. Brion, Roy Heyne, L. Steven Brown, Theresa Jacob, Audrey Edwards, Cheryl S. Lair, Myra H. Wyckoff, David B. Nelson, Dimitrios Angelis

    Background: This study was designed (1) to compare growth, morbidity and mortality in < 33-week gestational age (GA) (very preterm, VPT) or very low birth weight (BW < 1500 grams, VLBW) infants before (Epoch-1) and after implementing routine enteral zinc (Zn) supplementation (Epoch-2) to meet recommendations, and (2) to assess serum Zn levels and associated variables. Methods: Single-center prospective cohort of 826 infants. The primary outcome was the change (Δ) in Z-scores of accurate length (Δlength z ), weight and head circumference from birth to discharge home. Results: In Epoch-2 vs Epoch-1 Δlength z adjusted for confounding variables increased by 0.27 [95% confidence interval (CI) 0.13, 0.42, P < 0.001]. However, morbidity and mortality did not change. In Epoch-2 Zn decreased with GA and postnatal age: low ( < 0.74 mcg/mL) levels were observed in 51% infants. Retinopathy of prematurity (ROP) was independently associated with the lowest Zn [adjusted odds ratio 0.042 (CI 0.006, 0.306), area under the curve=0.928]. Conclusion: Routine enteral Zn supplementation was independently associated with improved linear growth but did not prevent occurrence of low Zn. ROP was independently associated with the lowest Zn. Implications: Multicenter studies are needed to assess whether dosage of enteral Zn should be increased and whether Zn could help prevent ROP. Impact: Implementation of routine enteral zinc (Zn) supplementation was associated with improved linear growth from birth to discharge and a more frequent physiologic growth curve in preterm very low birth weight infants. Serum Zn levels decreased with gestational age and with postnatal age. Low serum Zn levels were observed frequently despite routine Zn supplementation as currently recommended, which suggests a need to re-evaluate current enteral zinc supplementation guidelines for this population. Retinopathy of prematurity among infants < 33 weeks’ gestation was independently associated with low gestational age, low birthweight, stage of bronchopulmonary dysplasia and the lowest serum Zn level.


  • Open Access

    The role of zinc in the premature brain: functions, outcomes and future research perspectives

    by Myrsini Chamakioti, Luc P Brion, Pranav Viswanathan, Cheryl S Lair, Dimitrios Angelis

    Zinc (Zn) is one of the most prevalent and essential micronutrients, found in 10% of all human proteins and involved in numerous cellular enzymatic pathways. Zn is important in the neonatal brain, due to its involvement in neurotransmission, synaptic plasticity, and neural signaling. It acts as a neuronal modulator and is highly concentrated in certain brain regions, such as the hippocampus, and the retina. Low Zn intake is frequent in several countries and in populations with high poverty index. Preterm infants are at risk for Zn deficiency for prenatal (missing fetal Zn) and postnatal reasons (less intestinal absorption and insufficient intake in maternal milk to match fetal accretion). The amount of Zn needed for preterm infants is not known and remains the subject of controversy. Recent nutritional recommendations favored an increase in daily Zn supplementation. Systematic reviews of randomized trials have shown that Zn supplementation in preterm infants increases weight gain and may decrease mortality. In this review we will summarize the role of Zn in brain functions and outcomes in preterm newborns, gaps in knowledge and areas of future research.


  • Subgaleal hemorrhage in neonates: a comprehensive review and summary recommendations

    by Kikelomo Babata, Gayathri Vadlamudi, Nicole A. Bailey, Shamaila Gill, Pranav Viswanathan, Rafael Sillero, Tina Seidu, Kate Louise Mangona, Rachel Leon, Dimitrios Angelis

    Subgaleal hemorrhages (SH) involve bleeding in the expansive compartment between the periosteum of the skull and the galea aponeurotica. The potentially rapid accumulation of blood in this space is responsible for the clinical severity, as neonates with SH can present with acute hypovolemia, shock and multiorgan failure. SH is associated with instrumented delivery, especially with use of vacuum extraction. Although infrequent, the incidence of SH has not decreased over the past several decades, despite improvements in obstetrical care. Management of severe SH is complex and requires cardiovascular support, management of co-existent encephalopathy, and most importantly correction of coagulopathy and anemia.


  • Human Parechovirus (HPeV) infections: clinical presentations, patterns, and evolution of neonatal brain injury

    by Marina S. Oren, Rebekah L. Clarke, Michael Price, Jennifer M. Thomas, Michelle Machie, Alison M. Dolce, Lina F. Chalak, Dimitrios Angelis


  • Open Access

    Hyperglycemia and prematurity: a narrative review

    by Dimitrios Angelis, Mambarambath A. Jaleel, Luc P. Brion

    Hyperglycemia is commonly encountered in extremely preterm newborns and physiologically can be attributed to immaturity in several biochemical pathways related to glucose metabolism. Although hyperglycemia is associated with a variety of adverse outcomes frequently described in this population, evidence for causality is lacking. Variations in definitions and treatment approaches have further complicated the understanding and implications of hyperglycemia on the immediate and long-term effects in preterm newborns. In this review, we describe the relationship between hyperglycemia and organ development, outcomes, treatment options, and potential gaps in knowledge that need further research. Impact Hyperglycemia is common and less well described than hypoglycemia in extremely preterm newborns. Hyperglycemia can be attributed to immaturity in several cellular pathways involved in glucose metabolism in this age group. Hyperglycemia has been shown to be associated with a variety of adverse outcomes frequently described in this population; however, evidence for causality is lacking. Variations in definitions and treatment approaches have complicated the understanding and the implications of hyperglycemia on the immediate and long-term effects outcomes. This review describes the relationship between hyperglycemia and organ development, outcomes, treatment options, and potential gaps in knowledge that need further research.


  • Developmental changes of the fetal and neonatal thyroid gland and functional consequences on the cardiovascular system

    by Ioanna Kotsopoulou, Arpita K. Vyas, Melinda J. Cory, Christina S. Chan, Jawahar Jagarapu, Shamaila Gill, Manjula Mudduluru, Dimitrios Angelis

    Thyroid hormones play an important role in the development and function of the cardiac myocyte. Dysregulation of the thyroid hormone milieu affects the fetal cardiac cells via complex molecular mechanisms, either by altering gene expression or directly by affecting post-translational processes. This review offers a comprehensive summary of the effects of thyroid hormones on the developing cardiovascular system and its adaptation. Furthermore, we will highlight the gaps in knowledge and provide suggestions for future research.